OPEN ACCESS: All - Rory Watson
- 1Brussels
The European Medicines Agency has set out how it intends to ensure greater access to clinical trial data. The year long process will see the new policy in force from 1 January 2014 and reflects the agency’s move towards a more proactive publication policy.1
The final route map reflects input from experts across the European healthcare system and the drug industry at a workshop in London on 22 November. The agency’s director, Guido Rasi, made clear to participants the new policy of publishing clinical trial data once the marketing authorisation …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking